• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
CHENG Lu, LIN Yunfei, DING Li, WEN Aidong, WU Yan, ZHANG Run. Pharmacokinetics of butoconazole nitrate suppositories in human[J]. Journal of China Pharmaceutical University, 2013, 44(6): 548-552. DOI: 10.11665/j.issn.1000-5048.20130612
Citation: CHENG Lu, LIN Yunfei, DING Li, WEN Aidong, WU Yan, ZHANG Run. Pharmacokinetics of butoconazole nitrate suppositories in human[J]. Journal of China Pharmaceutical University, 2013, 44(6): 548-552. DOI: 10.11665/j.issn.1000-5048.20130612

Pharmacokinetics of butoconazole nitrate suppositories in human

More Information
  • The aim of the study was to investigate the pharmacokinetics of butoconazole nitrate suppositories in healthy Chinese female volunteers after single and multiple-dose vaginal administration. 12 healthy Chinese female volunteers received single 0. 05 g, single 0. 1 g, multiple doses(0. 1 g per day, 3-day consecutive administration)and multiple doses(0. 1 g per day, 5-day consecutive administration)of butoconazole nitrate suppositories. For 0. 05 g and 0. 1 g single vaginal administration of butoconazole nitrate suppositories, the cmax were(0. 895 0±0. 261 0)and(1. 740±0. 511)ng/mL and the AUC0-96 h were(36. 38±10. 82)and(73. 48±28. 99)ng ·h/mL, respectively. In the range of 0. 05-0. 1 g, butoconazole demonstrated linear pharmacokinetics. In the multiple-dose study at 0. 1 g dose for 3 consecutive days, the degree of fluctuation(DF)was(0. 54±0. 27), and the accumulation parameters Rcmax and RAUC0-τ were(1. 3±0. 3)and(1. 4±0. 3), respectively. In the multiple-dose study at 0. 1 g dose for 5 consecutive days, the DF was(0. 64±0. 25), and the accumulation parameter Rcmax and RAUC were(1. 4±0. 3))and(1. 6±0. 2), respectively. An accumulation of 60% in AUC0-τ occurred after a multiple administration. The main pharmacokinetic parameters between 3-day consecutive administration and 5-day consecutive administration showed no significant difference.
  • [1]
    Jacobson JB,Hajman AJ,Wiese J,et al.A new vaginal antifungal agent-butoconazole nitrate[J].Acta Obstet Gyn Scan,1985,64(3):241-244.
    [2]
    Adamson GD, Brown D Jr, Standard JV, et al. Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis[J].J Reprod Med,1986,31(2):131-132.
    [3]
    Hajman AJ. Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream[J].J Int Med Res,1988,16(5):367-375.
    [4]
    Brown D,Henzl MR,Kaufman RH.Butoconazole nitrate 2% for vulvovaginal candidiasis.New,single-dose vaginal cream formulation vs.seven-day treatment with miconazole nitrate.Gynazole 1 study group[J].J Reprod Med,1999,44(11):933-993.
    [5]
    US FDA.Guidance for industry: bioanalytical method validation [EB/OL].USA,US Department of Health and Human Services,2001[2011-09-10].http: //www.fda.gov /downloads /Drugs /Guidance Compliance Regulatory Information /Guidances / UCM070107.pdf.
    [6]
    Chu Y,Ding L,Liu HY,et al.Determination of potassium oxonate in human plasma and urine and its pharmacokinetics and accumulation evaluation in human[J].J China Pharm Univ(中国药科大学学报),2011,42(5):436-442.
    [7]
    Droegemueller W,Adamson DG,Brown D,et al.Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis[J].Obstet Gynecol,1984,64(4):530-534.
    [8]
    Tatum DM, Eggleston M. Butoconazole nitrate[J]. Infect Cont Hosp Ep,1988,9(3):122-124.
    [9]
    Wang Q,Chen GS.Progress in vaginal delivery systems[J].Chin J Mod Appl Pharm(中国现代应用药学),2005,22(1):34-36.
  • Related Articles

    [1]LIU Yuexin, WU Xiao, GUAN Rong, HANG Taijun, SONG Min. Comparative pharmacokinetics of active anthraquinones ingredients after oral administration of Rhei Radix et Rhizoma and Niuhuang Jiedu Tablets to rats[J]. Journal of China Pharmaceutical University, 2018, 49(4): 449-455. DOI: 10.11665/j.issn.1000-5048.20180410
    [2]XIE Zhen, WANG Xueyan, ZHAO Xin, ZHANG Jingzhao, TANG Xudong. Pharmackinetics of Reduning injection for nasal administration in rabbits[J]. Journal of China Pharmaceutical University, 2016, 47(5): 599-602. DOI: 10.11665/j.issn.1000-5048.20160516
    [3]LI Jingjing, TAN Jingfu, YANG Jie, WANG Qiang. Pharmacokinetic study of corosolic acid in normal rats and diabetic rats by LC-MS[J]. Journal of China Pharmaceutical University, 2014, 45(1): 84-87. DOI: 10.11665/j.issn.1000-5048.20140115
    [4]FANG Chang-jin, SONG Min, HANG Tai-jun, ZHANG Xiao-lei, SU Hao-ming, JIANG Cui-cui. Pharmacokinetics of berberine,jatrorrhizine and palmatine in Beagle dogs after oral administration of Ermiao Wan[J]. Journal of China Pharmaceutical University, 2012, 43(5): 438-442.
    [5]WU Fei, GAO Fang, DING Li, MAO Xiao-ming, MA Peng-cheng. Determination of zofenopril and its active metabolite zofenoprilat by a new derivative LC-MS method and their pharmacokinetics in healthy Chinese volunteers[J]. Journal of China Pharmaceutical University, 2009, 40(4): 353-358.
    [6]Determination of Pseudoephedrine in Dog Plasma by LC-MS and Study of Its Pharmacokinetics[J]. Journal of China Pharmaceutical University, 2004, (6): 47-50.
    [7]LC-MS Determination of Sulbactam in Beagle Dog Plasma and Study on its Pharmacokinetics When Co-administrated with Ceftazidime[J]. Journal of China Pharmaceutical University, 2004, (5): 47-50.
    [8]Pharmacokinetics of Ferric Acid in Rat after Oral Administration of Radix Angelica Sinensis, Rhizoma Chuanxiong and Their Compound Preparations[J]. Journal of China Pharmaceutical University, 2003, (5): 62-65.
    [9]Determination of Clindamycin and Its Pharmacokinetics in Human Plasma by LC-MS[J]. Journal of China Pharmaceutical University, 2002, (1): 30-33.
    [10]Pharmacokinetic and Relative Bioavailability of Gliclazide Tablets After a Single Oral Administration in Healthy Subjects[J]. Journal of China Pharmaceutical University, 1998, (3): 67-70.

Catalog

    Article views (1240) PDF downloads (1641) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return